The Guardian reports that a new genetic risk test for breast cancer may give clearer risk estimates.
Smithsonian magazine says researchers prioritize which organisms to sequence based on their possible medical benefits or ability to inform them about the past.
In PLOS this week: nasopharyngeal microbiota among young children, splice variant linked to oculocutaneous albinism in a dog breed, and more.
A new study suggests that gene therapy could help boys with the brain disease adrenoleukodystrophy, the New York Times reports.
The Food and Drug Administration says that modified mosquitos that act as pesticides are not drugs, according to the Associated Press.
A research trio traces the origin of genital herpes in humans to Paranthropus boisei, according to LiveScience.
In Science this week: ancient Neanderthal and human genomes, and more.
Retraction Watch reports that Nature has added an editor's note to a paper describing the correction of a pathogenic mutation in human embryos.
Parents are lobbying for more states to add adrenoleukodystrophy to newborn genetic screening tests, NPR reports.
The New York Times looks into ancient endogenous retroviruses within the genome.
In Nature this week: Critical Assessment of Metagenome Interpretation results, and more.
New Nobel Prize winners tell the Boston Globe that science funding these days is uncertain.
Researchers model two RNA world scenarios to explore how life on Earth might have emerged, Newsweek reports.
New Scientist writes that CRISPR could be used to treat a number of diseases if issues surrounding delivery could be solved.
In Genome Biology this week: computational approach for analyzing noisy single-cell sequencing profiles, eQTLs of dilated cardiomyopathy, and more.
Using base editing, a Chinese research team has repaired a β-thalassemia-causing mutation in cloned embryos, Nature News reports.
The Telegraph reports that philosopher Jeremy Bentham is to have his DNA tested.
The New York Times looks into personal genetic testing and what it can offer people.
In PNAS this week: innate immune interactions with TB bug, cytoplasmic microtubule organizing center-like structure, and more.
Tom Price, the secretary of the US Department of Health and Human Services, resigned Friday.
A French startup plans to use gene-editing tools to disrupt pathogenic bacteria in the gut microbiome, according to Futurism.
Jeremy Farrar, the director of the Wellcome Trust, writes at the Guardian that science is a team endeavor.
In PLOS this week: genetic diversity of Trypanosoma cruzi, sequencing analysis of Chlamydia from turtles, and more.
According to Slate, some people prefer not to know their genetic risk of certain diseases.
Technology Review notes that states like Maryland and New York limit direct-to-consumer genetic testing.
New study finds bias against female lecturers among student course evaluations, the Economist reports.
A research duo finds that science and technology graduate students who turn away from academic careers do so because of changes in their own interests.
Students whose classmates are interested in science are more likely to think about a career in science, technology, engineering, and mathematics, a new study says.
CNBC reports that the genetic counseling field is expected to grow as personalized medicine becomes more common.